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The genetic epidemiology of variation in bone mineral density (BMD) and osteoporosis is 
not well studied in Iranian populations and needs more research. We report a candidate 
gene association study of BMD variation in a healthy cross-sectional study of 501 males 
and females sampled from the Iranian Multi-Centre Osteoporosis Study, Shiraz, Iran. 
We selected to study the association with 21 single nucleotide polymorphisms (SNPs) 
located in the 7 candidate genes LRP5, RANK, RANKL, OPG, P2RX7, VDR, and ESR1. 
BMD was measured at the three sites L2–L4, neck of femur, and total hip. Association 
between BMD and each SNP was assessed using multiple linear regression assuming 
an allele dose (additive effect) on BMD (adjusted for age and sex). Statistically significant 
(at the unadjusted 5% level) associations were seen with seven SNPs in five of the 
candidate genes. Two SNPs showed statistically significant association with more than 
one BMD site. Significant association was seen between BMD at all the three sites 
with the VDR SNP rs731246 (L2–L4 p = 0.038; neck of femur p = 0.001; and total hip 
p < 0.001). The T allele was consistently associated with lower BMD than the C allele. 
Significant association was also seen for the P2RX7 SNP rs3751143, where the G allele 
was consistently associated with lower BMD than the T allele (L2–L4 p = 0.069; neck of 
femur p = 0.024; and total hip p = 0.045).
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inTrODUcTiOn
Osteoporosis is a skeletal disorder characterized by a reduction in the strength of bone with a 
consequent increase in bone fragility and susceptibility to fracture. Low bone mass is associated 
with micro-architectural deterioration of bone tissue (1). The loss of strength and bone mass can 
be as a result of a multitude of factors including the inability to reach optimal peak bone mass 
in early adulthood, increased resorption of bone having reached peak mass, or dysfunction of 
bone formation during bone remodeling (2). In this regard, hip fractures are the most important 
complication associated with osteoporosis and are linked to morbidity and mortality. While the 
cause of death is often due to other chronic disease, 25% of deaths are directly linked to the 
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hip fracture or complications arising from the fracture such 
as pressure sores, infection, and bronchopneumonia (3). The 
12-month survival rate post-hip fracture in the UK is 63% for 
men and 75% for women. In addition, one in two women and 
one in five men who are aged over 50 years will have suffered 
from an osteoporotic fracture in their remaining lifetime (4).
It is expected that by 2050, the world population will increase; 
as a result, it is also thought that the population of elderly people 
will grow (4). In the UK, by the year 2020, the over 85 years old age 
group is estimated to rise to 2.1 million, whereas this population 
was 1.2 million in 2002 (5). This increase in the aging population 
in the UK is predicted to cause double the number of osteoporotic 
fractures over the next 50 years (6). On this subject, genetic fac-
tors are important in the pathogenesis of osteoporosis, with links 
to a reduction in bone mineral density (BMD) and an increased 
susceptibility to osteoporotic fractures (7). Although genetic 
effects on BMD are mediated by several genetic factors with mild 
influences, more studies are needed for determining the relation 
between genetic factors and bone loss (8). In this regard, genome-
wide association studies (GWAS) and candidate gene association 
studies are the two robust approaches to investigate correlation 
between genetic variation and disease risk to identify genome 
regions or candidate genes that contribute to osteoporosis disease 
(9, 10). The data obtained from these two approaches are growing 
with some suggestion of ethnic differences in the genetic associa-
tions with BMD (11).
The genetic epidemiology of variation in BMD is not well stud-
ied in Iranian populations and needs more research. To this end, 
we set out to examine the relative contributions of seven major 
candidate genes to BMD variation in a healthy cross-sectional 
study of males and females sampled from Shiraz, Iran.
MaTerials anD MeThODs
study Participants and Phenotypes
Subjects for the study were selected from The Shiraz Centre of 
the Iranian Multi-Centre Osteoporosis Study (IMOS), which 
is an ongoing study to determine reference values for bone 
densitometry in the female and male Iranian population from 
2005. In the Shiraz Centre, 540 healthy subjects aged 20–75 years 
were selected randomly from 1080 subjects who were registered 
in the IMOS cohort and invited to participate in this study. Five 
hundred and one responded to the invitation and consented to 
participate (This sample of subjects is referred to as IMOS-AD 
throughout this report.). The study protocol was approved by the 
Research Ethics Committee of the Shiraz Medical University of 
the Iranian Ministry of Health and Medical Education. All the 
participants provided written informed consent after being fully 
informed of the nature of the study (in accordance with Helsinki 
Declaration).
Height was read from a free-standing height with the near-
est 0.5 cm. Subsequently, subjects were weighed and body mass 
index (BMI) was calculated (kilograms per square meter).
identifying candidate genes
We aimed to study variants with established associations 
with BMD variation in other populations and/or those with 
relevance to the Iranian population. The genes with established 
associations were selected if evidence for association was 
reported and replicated through a candidate gene association 
study (CGAS), a meta-analysis of candidate gene association 
study (MA-C), a GWAS, and a meta-analysis of genome-wide 
association study (MA-G). Six key publications were used to 
select the genes with well-replicated associations with BMD 
(12–17). This led to the selection of LRP5, RANK, RANKL, 
OPG, and ESR1 as these associations were reported by 
CGAS, MA-C, GWAS, and MA-G studies. These genes are 
also involved in three biological pathways, the Wnt/-catenin 
signaling pathway, the estrogen endocrine pathway, and the 
RANKL/RANK/OPG pathway. The VDR gene was also selected 
as it is the candidate gene related to osteoporosis most studied 
in Iranian populations (18, 19). P2RX7 was also selected as 
it was a novel candidate gene (at the time of recruiting the 
subjects to the study) associated with BMD and osteoporotic 
fracture risk (20, 21).
snP selection
Genome-wide association studies literature review was used 
for the strategic selection of single nucleotide polymorphisms 
(SNPs) that were the most relevant in BMD. The catalog of 
published GWAS in the National Human Genome Research 
Institute (NHGRI) was used to select associated SNPs for the 
selected candidate genes (22). This resulted in a total of 22 SNPs 
for the candidate gene association analysis with BMD variation 
in the IMOS-AD study. The specific SNPs selected were rs599083 
(LRP5), rs3736228 (LRP5), rs884205 (RANK), rs3018362 
(RANK), rs9594738 (RANKL), rs9594759 (RANKL), rs1021188 
(RANKL), rs6469804 (OPG), rs4355801 (OPG), rs2062375 
(OPG), rs2062377 (OPG), rs11995824 (OPG), rs2504063 
(ESR1), rs1999805 (ESR1), rs4870044 (ESR1), rs1038304 (ESR1), 
rs2941740 (ESR1), rs6929137 (ESR1), rs3751143 (P2RX7), 
rs28360457 (P2XR7), rs731236 (VDR), and rs2228570 (VDR).
Bone Mineral Density
Bone mineral densitometry was performed by dual-energy X-ray 
absorptiometry (DEXA) method (GE Lunar DPX-IQ Bone 
densitometer, GE Healthcare, Madison, WI, USA). It was used 
to measure appendicular and axial sites and measurements are 
reported in units of milligrams per square centimeter. Minimal 
radiation exposure was performed as produced in the method by 
Blake and Fogelman (23). Definitive data of BMD measurements 
of the total proximal femur and lumbar vertebrae (L2–L4) in the 
anterior–posterior position were obtained.
Blood sampling and Dna extraction
Blood sampling was performed by the brachial vein puncture 
method (24, 25), and 200  μl of peripheral blood was col-
lected from each participant in an EDTA tube. Finally, there 
were 501 participants whose blood samples and BMD were 
available.
The collected peripheral blood samples were subjected to 
DNA extraction through application of QIAamp 96 DNA Blood 
Kit. Finally, the extracted DNA samples were assessed by spec-
trophotometric measurements. The quality and purity of DNA 
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was checked using a NanoDrop-1000 spectrophometer (Thermo 
Scientific) with an OD 260/280 ratio between 1.8 and 2 used as 
the criteria for acceptable DNA purity.
genotyping
Genotyping of the selected SNPs was performed by Competitive 
Allele-Specific Polymerase chain reaction (KASPar) assay 
(KBioscience services; United Kingdom). The KASPar assay SNP 
genotyping system from KBioscience is based on fluorescent 
resonance energy transfer (FRET) technology. Following com-
pletion of the reaction, the data reported were evaluated using 
the KlusterCaller 1.1 software (KBioscience). Hardy–Weinberg 
equilibrium analysis was conducted for quality control. One 
SNP (rs9594759) gave a p-value below the threshold of 0.001 
(26) and was excluded from further analysis, so final results are 
presented for 21 SNPs only. All included SNPs had a call rate in 
excess of 95%.
All assays were tested on LGC Genomics’ in-house validation 
DNA prior to being run on the study samples. Assays were deemed 
to be working successfully when clusters were distinct and call 
rates consistently high. The data are automatically quality control 
checked on a per SNP basis. No template controls (NTCs) were 
included on each plate to enable the detection of contamination 
or non-specific amplification – these samples must not amplify 
during the reaction.
The number of genotypes that were callable must be greater 
than 90% and minor allele frequency should be greater than 2% 
unless the SNP is known to be a very low frequency.
statistical analysis
GraphPad Prism 6 and IBM® SPSS® were used to analyze the 
data. The comparison of means for two independent groups was 
analyzed using the Student’s t-test. The t-test was used for all two 
group comparisons as the sample size in each group was always 
in excess of 50; the variables were approximately normally dis-
tributed, and sample SDs were similar. The association between 
BMD and the number of copies of the minor allele was analyzed 
using linear regression with the BMD variable as the outcome 
adjusting for the covariates age and sex of participant. For each 
linear regression analysis, the SNP genotype was coded as 0, 1, or 
2 in terms of how many copies of the minor allele they carried. 
We decided to adjust for these two common confounders as this 
adjustment has been done in other studies (15) and adjusting for 
more covariates would reduce the statistical power. The adjusted 
association is reported along with 95% confidence intervals 
(95% CI). All reported p-values are nominal and not adjusted for 
multiple testing.
The power of the patient sample size of 501 to detect true 
associations depends upon the frequency of the genotypes. If 
the frequency of the common homozygote and the heterozygote 
were similar (each around 40%), then the sample would have 
90% power to detect a true association responsible for a dif-
ference of 0.23 of a SD in BMD. If the heterozygote is as rare 
as 16% and the homozygote has frequency of 84%, then 501 
patients would have 90% power to detect a difference in BMD 
of 0.4 of a SD. These calculations assume a two-sided 5% type 
1 error rate.
resUlTs
The BMi of the Males and Females within 
a random selection of subjects from an 
iranian Population
Each subject was supplied with a questionnaire from which 
demographic variables for this study including age, height, weight, 
and BMI were determined. The data were analyzed separately by 
gender as BMI is known to be higher in females than in males in 
the Iranian population (27). Menopausal status was recorded on 
the women, and 111 of the 248 women were postmenopausal. 
Statistical differences between genders were formally compared 
using a Student’s t-test. Statistical analysis showed that there were 
no statistically significant differences in age between the male 
and female subjects of our sample group, but the male subjects 
within our sample population had significantly higher weight 
and height metrics compared to the female subjects (p < 0.001). 
The calculated BMI was higher for females than for the male sub-
jects within the selected Iranian population sample (p < 0.001) 
(Table 1).
The BMD of the Males and Females within 
a random selection of subjects from an 
iranian Population
The L2–L4 (L2–L4_BMD), neck of femur (Neck_BMD), and 
total hip BMD (Total_BMD) of the IMOS-AD sample consisting 
of 501 individuals was assessed using the DXA Scanner. Data 
from the whole sample population were separated into male 
and female groups to examine any gender associations with 
BMD. The gender-specific group means were compared using a 
Student’s t-test.
Analysis of the Iranian sample population showed that the 
male subjects had statistically significantly higher BMD means 
associated with L2–L4_BMD, neck_BMD, and total_BMD com-
pared to that of the female population (p < 0.001) (Table 2).
analysis of genotyping Data of 21 snPs in 
seven selected candidate genes and 
BMD in the iranian subjects
LRP5, RANK, RANKL, ESR1, VDR, P2XR7, and OPG were 
selected following the literature review of genes for consideration 
in an Iranian population. The genetic association analysis was 
conducted assuming an additive allelic effect on the outcome vari-
able BMD. The analysis was repeated for each BMD variable and 
for each SNP (i.e., 3 × 21 linear regression analyses). Regression 
analyses were performed adjusting for age and sex. The results in 
Table 3 show the linear regression coefficient for the association 
between the BMD outcome and the number of copies of the risk 
allele.
Table 3 shows the association analyses grouped by SNP. Out of 
a total of 63 regression analyses of the data, 10 tests are statistically 
significant at the 5% level (three would be expected under the null 
hypotheses). However, the most notable result here is of the VDR 
polymorphism rs731236, which shows a statistically significant 
association at all the three BMD sites. The allele T is associated 
TaBle 2 | summary of BMD measurements in participants.
BMD of participants
Variable Total 
Mean (sD) 
Median (iQr)
Female 
Mean (sD) 
Median (iQr)
Male 
Mean (sD) 
Median (iQr)
p-Value
L2–L4_BMD 1.031 (0.17) 1.001 (0.17) 1.060 (0.15) <0.001
1.030 (0.93–1.14) 1.030 (0.89–1.12) 1.031 (0.94–1.17)
Neck_BMD 0.870 (0.15) 0.827 (0.14) 0.918 (0.14) <0.001
0.862 (0.77–0.96) 0.821 (0.75–0.92) 0.903 (0.81–1.00)
Total_BMD 0.906 (0.15) 0.864 (0.15) 0.952 (0.13) <0.001
0.904 (0.82–1.00) 0.876 (0.79–0.95) 0.938 (0.85–1.04)
All BMD measurements are reported in mg/cm2. The female subjects had lower BMD values compared to male subjects. N = 501, Student’s unpaired t-test.
TaBle 1 | Physical characteristics of both male and female study subjects.
statistical evaluation of the demographic characteristics of female and male subjects
Variable Total 
Mean (sD) 
Median (iQr)
Female 
Mean (sD) 
Median (iQr)
Male 
Mean (sD) 
Median (iQr)
p-Value
Age (years) 47.5 (16.0) 46.7 (15.7) 48.3 (16.3) 0.19
47.0 (35.0–59.5) 47.0 (34.0–59.0) 47.0 (37.0–60.0)
Height (cm) 161.2 (9.6) 154.5 (5.8) 168.4 (7.4) <0.001
160.0 (154.0–168) 155.0 (151.0–159.0) 168.0 (163.0–172.0)
Weight (kg) 64.5 (11.8) 62.2 (11.8) 66.9 (11.4) <0.001
64.0 (56.0–72.0) 62.0 (54.0–70.3) 66.5 (58.0–73.0)
BMI (kg/m2) 24.8 (4.4) 26.1 (4.6) 23.6 (3.67) <0.001
24.5 (21.5–27.6) 26.0 (22.3–29.6) 23.3 (20.1–25.9)
The age, height, weight, and BMI of females and males were summarized and compared. The male subjects had lower BMI values compared to female subjects. N = 501, Group 
specific means are compared using Student’s t-test. IQR, interquartile range.
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with lower BMD after adjusting for age and sex. The P2RX7 allele 
G for SNP rs3751143 is statistically significantly associated with 
lower BMD at two sites (the neck and total hip) and is marginally 
associated at the L2–L4 site.
DiscUssiOn
This study looked at whether the BMD of a random selection of 
subjects from an Iranian population was genetically associated 
with a selection of candidate genes known to be associated with 
BMD. A total of 21 SNPs in 7 selected genes were evaluated for 
this study. The descriptive analysis of our random selection of 
subjects from the Iranian population showed that there were no 
significant differences between the mean ages of the males and 
females within the group. Additionally, the weight and height of 
the males were higher than that of the females, as observed in 
similar subject groups of other similar Iranian studies (27). These 
data are an indication that as the demographic characteristics of 
the randomly selected sample group was comparable to samples 
within other studies; further genetic studies would also be com-
parable to the literature. It is of interest to note that these data 
showed that male subjects had a lower BMI range compared to 
the female subjects and these data were consistent with findings 
from Bahrami et al. (27).
Data collected from the BMD analysis of our Iranian popula-
tion samples showed that the total hip BMD of the male subjects 
was higher than the female subjects. The average BMD of our 
male sample group was 0.95  mg/cm2, and the females had an 
average BMD value of 0.86 mg/cm2. These data were consistent 
with BMD data obtained from other Iranian groups (28, 29), 
European groups (30) and American groups (31). These data sug-
gest that the BMD pattern observed within our sample group was 
comparable to that of others used in similar genetic association 
studies (32, 33).
As mentioned previously, a low BMD is associated with the 
risk of developing osteoporosis (34). The relationship between 
BMD and BMI, including its weight and height constituents, is 
widely reported (35–37). In the literature, BMD is reported to be 
lower in lean postmenopausal women in the majority of studies. 
However, some studies have also reported increased BMD in lean 
postmenopausal women (38).
It is expected that many different genetic variants contribute to 
the regulation of BMD. Most of the variants are assumed to have 
small effect size, but there is evidence that rare variants of large 
effect size also contribute in some individuals (39). In the past 
10 years, there have been advances in the identification and valida-
tion of osteoporosis susceptibility loci via large-scale association 
studies, meta-analyses, and GWAS of SNPs. A thorough review 
of latter developments has revealed that more than 15 genes can 
be assigned as confirmed BMD genes linked to osteoporosis (40).
The LRP5, RANK, RANKL, P2RX7, ESR1, OPG, and VDR 
genes selected for this study are known to have important roles 
in four well-defined biological pathways; the estrogen endocrine 
pathway, the Wnt/β-catenin signaling pathway, the RANKL/
TaBle 3 | a summary of association between BMD and 21 selected snPs.
summary of analysis by snP and BMD site
snP (gene) Minor  
allele
Per allele  
(95% confidence interval)
p-Value
rs599083 (LRP5) G
L2–L4 −0.013 (−0.032 to 0.006) 0.177
Neck 0.001 (−0.014 to 0.016) 0.868
Total hip 0.003 (−0.012 to 0.018) 0.732
rs3736228 (LRP5) T
L2–L4 −0.026 (−0.057 to 0.005) 0.103
Neck 0.008 (−0.016 to 0.033) 0.503
Total hip 0.014 (−0.011 to 0.039) 0.269
rs884205 (RANK) A
L2–L4 −0.009 (−0.034 to 0.015) 0.464
Neck −0.016 (−0.036 to 0.003) 0.101
Total hip −0.020 (−0.040 to −0.001) 0.042
Rs3018362 (RANK) A
L2–L4 −0.002 (−0.024 to 0.019) 0.846
Neck −0.004 (−0.021 to 0.013) 0.655
Total hip −0.005 (−0.022 to 0.012) 0.555
rs9594738 (RANKL) T
L2–L4 0.025 (0.004 to 0.047) 0.019
Neck 0.010 (−0.007 to 0.027) 0.236
Total hip 0.010 (−0.006 to 0.027) 0.225
rs1021188 (RANKL) C
L2–L4 −0.019 (−0.046 to 0.008) 0.161
Neck −0.012 (−0.034 to 0.009) 0.261
Total hip −0.018 (−0.040 to 0.003) 0.095
rs250463 (ESR1) A
L2–L4 0.003 (−0.017 to 0.022) 0.795
Neck −0.001 (−0.020 to 0.014) 0.860
Total hip −0.006 (−0.021 to 0.010) 0.465
rs1999805 (ESR1) A
L2–L4 −0.005 (−0.023 to 0.014) 0.628
Neck −0.002 (−0.016 to 0.013) 0.819
Total hip 0.004 (−0.010 to 0.019) 0.567
Rs4870044 (ESR1) T
L2–L4 −0.001 (−0.020 to 0.021) 0.935
Neck 0.001 (−0.015 to 0.017) 0.897
Total hip −0.000 (−0.016 to 0.016) 0.967
Rs1038304 (ESR1) G
L2–L4 0.015 (−0.005 to 0.036) 0.144
Neck 0.012 (−0.004 to 0.028) 0.141
Total hip 0.016 (−0.001 to 0.032) 0.062
Rs2941740 (ESR1) G
L2–L4 0.013 (−0.007 to 0.034) 0.203
Neck 0.060 (−0.014 to 0.019) 0.747
Total Hip 0.006 (−0.010 to 0.023) 0.448
Rs6929137 (ESR1) A
L2–L4 0.020 (−0.000 to 0.041) 0.054
Neck 0.007 (−0.000 to 0.024) 0.363
Total hip 0.015 (−0.002 to 0.031) 0.077
Rs7311236 (VDR) C
L2–L4 0.022 (0.001 to 0.043) 0.038
Neck 0.027 (0.011 to 0.044) 0.001
Total hip 0.029 (0.013 to 0.046)  < 0.001
summary of analysis by snP and BMD site
snP (gene) Minor  
allele
Per allele  
(95% confidence interval)
p-Value
Rs2228570 (VDR) C
L2–L4 0.014 (−0.007 to 0.036) 0.195
Neck 0.010 (−0.007 to 0.027) 0.248
Total hip 0.001 (−0.016 to 0.018) 0.918
Rs3751143 (P2RX7) G
L2–L4 −0.021 (−0.043 to 0.002) 0.069
Neck −0.020 (−0.037 to −0.003) 0.024
Total hip −0.018 (−0.035 to 0.000) 0.045
Rs28360457 (P2RX7) A
L2–L4 0.088 (−0.209 to 0.386) 0.559
Neck 0.078 (−0.156 to 0.312) 0.511
Total hip 0.073 (−0.164 to 0.310) 0.547
Rs6469804 (OPG) A
L2–L4 −0.023 (−0.043 to −0.003) 0.026
Neck −0.011 (−0.027 to 0.005) 0.195
Total hip −0.012 (−0.029 to 0.004) 0.129
Rs4355801 (OPG) A
L2–L4 −0.023 (−0.044 to −0.002) 0.029
Neck −0.010 (−0.026 to 0.007) 0.240
Total hip −0.013 (−0.029 to 0.003) 0.119
Rs2062375 (OPG) G
L2–L4 0.012 (0.008 to 0.032) 0.235
Neck 0.004 (−0.012 to 0.020) 0.638
Total hip 0.002 (−0.013 to 0.018) 0.761
Rs2062377 (OPG) T
L2–L4 0.017 (−0.004 to 0.037) 0.118
Neck 0.006 (−0.010 to 0.023) 0.452
Total hip 0.009 (−0.008 to 0.025) 0.301
Rs11995824 (OPG) G
L2–L4 −0.021 (−0.042 to −0.001) 0.044
Neck −0.011 (−0.027 to 0.006) 0.199
Total hip −0.013 (−0.029 to 0.005) 0.125
The association between BMD and the number of copies of the minor allele was 
analyzed using multiple linear regression with the BMD variable as the outcome, 
adjusting for the covariates age and sex of participant. For each linear regression 
analysis, the SNP genotype was coded as 0, 1, or 2 in terms of how many copies of 
the minor allele they carried. To illustrate the interpretation, consider two people with 
the same gender and age but with genotypes TT and CC at the SNP Rs7311236. The 
results of this analysis would predict the total hip BMD of the person with CC to be 
0.068 units higher than the person with genotype TT.
(Continued)
TaBle 3 | continued
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RANK/OPG pathway, and the vitamin D synthesis pathway 
(40). There are limited data related to effective genetic variants 
in osteoporosis, particularly in respect to the mentioned genes, 
in the Iranian population. The association analysis found 10 of 
the 63 tests resulted in p <  0.05 (Table  3). Under the null of 
no genetic association, we would only expect to see three of the 
results statistically significant. Hence, we do see some confirma-
tion of associations with this set of genetic loci in the Iranian 
sample. However, the SNPs selected for analysis in this cohort 
are already established as risk SNPs, so in this evaluation, we are 
mainly interested to know if the overall pattern of association is 
similar to other populations or may be different. Such differences 
may be due to different population, alleles, or the impact of a 
6Dastgheib et al. Iranian BMD Genetic Association Study 
Frontiers in Endocrinology | www.frontiersin.org October 2016 | Volume 7 | Article 141
distinct environment; hence, it is more the estimate and 95% 
CI that is of interest.
Out of the 21 selected SNPs, our genotyping data identified 
statistically significant associations between BMD and 7 of these 
SNPs: Rs731236, Rs3751143, Rs884205, Rs9594738, Rs4355801, 
rs6469804, and Rs11995824.
For the RANK gene, the present study showed that SNP 
rs884205 was associated with total hip BMD, and the same 
association was observed in studies by Styrkarsdottir et al. (30) 
within a European and East Asian population (15, 41). The pre-
sent study further showed that RANKL SNP rs9594738 was also 
closely linked to spine BMD, similar to studies by Duncan et al. 
and Styrkarsdottir et  al. in the European population (16,  42). 
The OPG SNPs rs2073804, rs1995824, and rs4355801 asso-
ciations with spine BMD determined in the present study were 
also observed in other studies specific to spine and hip BMD 
in post/premenopausal women and the European population, 
respectively (33, 43). Although there are few published data on 
P2RX7, one study did correlate with ours in that SNP rs3751143 
was associated with BMD in a similar number of subjects (44).
The most interesting result in our study is the association with 
the VDR SNP rs731246 (also known as TaqI), which is statisti-
cally significant over all the three measured BMD sites. Early 
work from Keen et al. (45) and Spector et al. (46) using UK Twin 
cohorts, as well as the work from Ferrari et  al. (47), led to the 
identification of common polymorphisms in the VDR as being 
associated with BMD and an important target for the treatment 
of osteoporosis. However, there have been conflicting results 
(48), and more importantly meta-analyses including this genetic 
variant have not found consistent evidence for its association with 
BMD variation or osteoporotic fracture risk (8, 49–51). However, 
one Iranian study has shown a statistically significant association 
with the VDR SNP rs2228570 and BMD in females, though they 
did not examine the SNP rs731246.
While this study is a substantial contribution to the genetic 
epidemiology of variation in BMD in the Iranian population, 
it does have limitations. The sample size is modest, and this 
means the study is powered to detect larger effects but limits 
the potential for adjustment for additional covariates (such as 
menopausal status and BMI, height or weight). Over-adjustment 
for covariates impacts statistical power. When studying the 
association between the SNP genotypes and BMD, it is pos-
sible that for some SNPs, there was an imbalance of post- and 
premenopausal women in the genotype groups and this might 
lead to a spurious association. However, including age and gender 
as covariates would mitigate this to some extent. This study had 
no information on incidence of fractures hence we cannot be 
confident any of these associations would extend to increased 
facture risk.
In conclusion, our data demonstrate that the overall pattern of 
association of these established risk SNPs in the Iranian popula-
tion are similar to those observed in other populations. From 
our data, we concur that BMD is genetically dependent (52), and 
that the VDR is statistically significantly associated with BMD 
in the Iranian population. Future prospective studies using this 
cohort would enable us to analyze fracture incidence, as well as 
the functional effects of these SNPs in bone cells.
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